Activated T-cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Activated T-cell therapy, covering 2016-02-17 to 2016-02-17. Get the full timeline:
Most recent: Clinical Trial Update: Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent [Phase 1]